We list the current GSK patents and patent applications that cover small molecules and their formulations, uses and processes for neglected tropical diseases on this site. The terms of the IP patent pool relate specifically to the development of medicines for the treatment of the identified diseases and only for use in least developed countries
For pool licensees looking to sell outside the least developed countries, we may be willing to discuss different options. The preferred option would be chosen on mutually agreed terms, on a case by case basis.
We have also included in the patent list some patent filings that include some compounds and uses GSK is actively developing. Licences for these patent filings could be considered if it related to a different neglected tropical disease therapy area, or a different compound covered by the patent that we are not currently developing.
Where a third party or institution has a contractual right in a GSK patent filing or know-how, we will seek permission for transferred use under this initiative.
Within certain guidelines, GSK will offer licences to third parties on available technologies on favourable terms that will include geographical and therapeutic area restrictions and other terms relevant to the transaction.
While it is right that we explore new ways of stimulating research that might otherwise not happen – and a patent pool is one such model - GSK will defend our IP robustly outside of the patents in the pool.
All requests for patent pool and know-how licences should be directed to us by email.*
* Please note that this email address should not be used for reporting side effects of medicines. If you want to report a side effect, please call the GSK Response Center in the US on 1-888-825-5249 or the Customer Contact Centre in the UK on 0800 221441. For other locations, please contact your local GSK office.
Building the best product pipeline in the industry
Find out more about our pipeline
